Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Saponins are amphipathic glycosides found in traditional Chinese medicines. In the present study, we isolated a panel of saponins from
Paris forrestii
(Takht.) H. Li, a unique plant found in Tibet and Yunnan provinces, China. By examining their activities in suppressing acute myeloid leukemia (AML) cell proliferation, total saponins from
Paris forrestii
(TSPf) displayed more potent activity than individual ones. TSPf induced more than 40% AML cell apoptosis and decreased the viability of all leukemia cell lines. TSPf-induced apoptosis was confirmed by both Annexin V staining and caspase-3 activation. In line with these findings, TSPf downregulated pro-survival proteins Mcl-1, Bcl-xL, and Bcl-2 but upregulated the expression of tumor suppressor proteins p53, p27, Bax, and Beclin 1. The AKT/
mTOR
signaling pathway is frequently overactivated in various AML cells, and TSPf was found to suppress the activation of both AKT and
mTOR
, but had no effects on their total protein expression. This was further confirmed by the inactivation of 4EBP-1 and p70S6K, two typical downstream signal molecules in the AKT/
mTOR
pathway. Moreover, TSPf-inactivated AKT/
mTOR
signaling was found to be associated with downregulated
RNF6
, a recently identified oncogene in AML.
RNF6
activated AKT/
mTOR
, and consistently, knockdown of
RNF6
led to inactivation of the AKT/
mTOR
pathway. Furthermore, TSPf suppressed the growth of AML xenografts in nude mice models. Oral administration of TSPf almost fully suppressed tumor growth without gross toxicity. Consistent with the findings in cultured cell lines, TSPf also downregulated
RNF6
expression along with inactivated AKT/
mTOR
signaling in tumor tissues. This study thus demonstrated that TSPf displays potent anti-AML activity by suppressing the
RNF6
/AKT/
mTOR
pathway. Given its low toxicity, TSPf could be developed for the treatment of AML.
...
PMID:Saponins From
Paris forrestii
(Takht.) H. Li Display Potent Activity Against Acute Myeloid Leukemia by Suppressing the RNF6/AKT/mTOR Signaling Pathway. 2999 4